Blog
Blog
Why Enterprise AI Feels Like a Disappointment for Life Sciences Teams
You have used tools like ChatGPT. They are fast, helpful, almost fun. Then your company deploys its own AI platform and something feels off. It hedges. It refuses. It does not understand your business, markets, or data. You are not imagining the gap.
Filter posts by:
Blog
2019 NRDL: Insights for Future Pricing Negotiations in China
China’s 2019 National Reimbursement Drug List (NRDL) update offers manufacturers key learnings and insights for future NRDL negotiations, particularly with respect to the negotiation tactics used in different disease areas; although in most disease areas the comparative negotiation rule was employed...
